CFMATTERS (FP7 Health project): Cystic Fibrosis microbiome determined antimicrobial therapy trial

CFMATTERS was the first randomized, controlled trial comparing the use of microbiome-directed antibiotic treatment versus standard therapy for patients with CF experiencing respiratory infections. The trial was coordinated by Prof. Barry Plant, University College Cork in Ireland and received funding from the European Union under the 7th framework programme.

These comments are moderated. Your comment will not be visible unless accepted by the content owner.

Only simple HTML formatting is allowed and any hyperlinks will be stripped away. If you need to include a URL then please simply type it so that users can copy and paste it if needed.

Note: Only shown to the creator of the post